- Lori Halverson
The Collaborative Genomics Conference is a bi-monthly web-based clinical case conference series which brings together laboratorians and clinicians from across the country to share interesting and unusual patient cases in the field of medical genetics, as well as educate one another about current and advanced genetic and genomic diagnostic technologies and guidelines. This series aims to keep learners updated on overall genetic knowledge, to enhance communication and genetic information across disciplines, and to ultimately improve clinical laboratory practices for enhanced patient care.
MD/DO, Genetic Counselors, Clinical Laboratorians, LGG Fellows, and Students.
|Kimberly Anderson, M.S., CGC, Chair||Lori Halverson, Coordinator||Kaitlin Sundling, MD, PhD|
|Celeste Eno, PhD||Hieu Nguyen, PhD|
|Xianging Shao, PhD||Morteza Seifi, PhD|
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
Disclosures for Planning Committee - January 1, 2023 – February 28, 2023
Disclosures for Planning Committee
Practice-Based Learning and Improvement
Employ Evidence-Based Practice
Apply Quality Improvement
INTERPROFESSIONAL EDUCATION COLLABORATIVE COMPETENCIES
ADDITIONAL ACTIVITY GOALS
|JAC 14||JAC 20|
IP — COMPETENCE
As a result of participation in this educational series, members of the healthcare team will be able to:
- Recognize both common and rare genetic abnormalities associated with developmental delay, infertility, prenatal ultrasound findings, and oncology specimens
- Demonstrate an improved ability to effectively communicate genetic information across healthcare professions and clinical team members
- Examine performance and utility of novel testing approaches and standardized classification recommendations